Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19

[1]  Hualiang Jiang,et al.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors , 2020, Nature.

[2]  Mary A Lake,et al.  What we know so far: COVID-19 current clinical knowledge and research. , 2020, Clinical medicine.

[3]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[4]  D. Jernigan,et al.  Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States, February 24, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[5]  Yechun Xu,et al.  Structure of Mpro from COVID-19 virus and discovery of its inhibitors , 2020, bioRxiv.

[6]  Yan Bai,et al.  Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.

[7]  W. Ko,et al.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges , 2020, International Journal of Antimicrobial Agents.

[8]  J. Rocklöv,et al.  The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.

[9]  T. Velavan,et al.  The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.

[10]  Alekh Gour,et al.  Drug Repurposing Approach for Developing Novel Therapy Against Mupirocin-Resistant Staphylococcus aureus. , 2019, Assay and drug development technologies.

[11]  P. Mishra,et al.  Molecular Docking and In Silico Cogitation Validate Mefenamic Acid Prodrugs as Human Cyclooxygenase-2 Inhibitor. , 2019, Assay and drug development technologies.

[12]  S. Goswami,et al.  Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Somdutt Mujwar,et al.  Prediction of riboswitch as a potential drug target and design of its optimal inhibitors for Mycobacterium tuberculosis , 2015, Int. J. Comput. Biol. Drug Des..

[14]  Somdutt Mujwar,et al.  Prediction of Riboswitch as a Potential Drug Target for Infectious Diseases: An Insilico Case Study of Anthrax , 2015 .

[15]  Bo Zhang,et al.  Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.

[16]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[17]  S. Baron.  Coronaviruses -- Medical Microbiology , 1996 .